IG VENA

This brand name is authorized in Austria, Hong Kong, Israel, Malta, Poland, Romania, Singapore, Tunisia

Active ingredients

The drug IG VENA contains one active pharmaceutical ingredient (API):

1 Human plasma protein of which human immunoglobulins at least 95% UNII 6D53G0FD0Z - PLASMA PROTEIN FRACTION (HUMAN)

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects. Read about Immunoglobulins, normal human, IV

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BA02	Immunoglobulins, normal human, for intravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 60992, 61005, 61006, 61007
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8652, 8653
Country: MT	Medicines Authority	Identifier(s): MA128/00301, MA128/00302, MA128/00303, MA128/00304
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100176888
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W43962001, W43963001, W43964001, W43965001, W68982001, W68982002, W68982003
Country: SG	Health Sciences Authority	Identifier(s): 14050P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 13043051H, 13043052H